Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Myeloid 1

Conditions

Burkitt Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Biphenotypic, Acute 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Extranodal NK-T-Cell 2Leukemia, Myeloid, Acute 2Sarcoma, Myeloid 1Recurrence 1Lymphohistiocytosis, Hemophagocytic 1Down Syndrome 1

Interventions

pegaspargase 3fludarabine phosphate 2Whole-Body Irradiation 2Tacrolimus 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Mycophenolic Acid 2Gemcitabine 2Etoposide 2Cyclophosphamide 2Busulfan 2Asparaginase 2tislelizumab 1sugemalimab 1selinexor 1pembrolizumab 1fludarabine 1Vorinostat 1Transplantation 1Tomography, X-Ray Computed 1Sirolimus 1Methylprednisolone 1Methotrexate 1Melphalan 1IMC-001 1Cyclosporine 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, Extranodal NK-T-Cell × Asparaginase × 90 days × Clear all
NCT07554482 2026-04-28

Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma

Beijing Tongren Hospital

Phase 2 Not yet recruiting
34 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT07525466 2026-04-13

Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)

Beijing Tongren Hospital

Phase 1/2 Recruiting
25 enrolled
LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡